相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats
Elizabeth M. Marchionne et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial
Gijs H. Goossens et al.
PLOS ONE (2012)
Increased Adipose Tissue Oxygen Tension in Obese Compared With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue Capillarization, and Inflammation
Gijs H. Goossens et al.
CIRCULATION (2011)
Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism A randomized controlled trial
Nynke J. van der Zijl et al.
DIABETES CARE (2011)
Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice
Young Sun Kang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Mitochondrial dysfunction and lipotoxicity
Patrick Schrauwen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Targeted Expression of Catalase to Mitochondria Prevents Age-Associated Reductions in Mitochondrial Function and Insulin Resistance
Hui-Young Lee et al.
CELL METABOLISM (2010)
Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose The DREAM trial
Anthony J. Hanley et al.
DIABETES CARE (2010)
Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance
Stefan Pscherer et al.
DIABETES CARE (2010)
Blockade of the RAS increases Plasma Adiponectin in Subjects with Metabolic Syndrome and Enhances Differentiation and Adiponectin Expression of Human Preadipocytes
F. S. Tian et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use
Weidong Chai et al.
HYPERTENSION (2010)
Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice
Banumathi K. Cole et al.
HYPERTENSION (2010)
Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice
Masaru Iwai et al.
JOURNAL OF HYPERTENSION (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycentic Control
Masanori Mitsuishi et al.
DIABETES (2009)
Reduced Adipose Tissue Oxygenation in Human Obesity Evidence for Rarefaction, Macrophage Chemotaxis, and Inflammation Without an Angiogenic Response
Magdalena Pasarica et al.
DIABETES (2009)
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action
E. J. Barrett et al.
DIABETOLOGIA (2009)
Direct Renin Inhibition Improves Systemic Insulin Resistance and Skeletal Muscle Glucose Transport in a Transgenic Rodent Model of Tissue Renin Overexpression
Guido Lastra et al.
ENDOCRINOLOGY (2009)
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
Ethan J. Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats
Marina C. Munoz et al.
JOURNAL OF HYPERTENSION (2009)
Angiotensin II and the development of insulin resistance: Implications for diabetes
J. Alberto Olivares-Reyes et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models
Yomiko Tomono et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat
Guido Lastra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Improved early-phase insulin response after candesartan treatment in hypertensive patients with impaired glucose tolerance
Katsunori Suzuki et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Inhibiting angiotensin type 1 receptors as a target for diabetes
Ulrich Kintscher et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Effects of anti hypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital Microscopy and histologic analysis
Bruno Sabino et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats
Damiano Rizzoni et al.
JOURNAL OF HYPERTENSION (2008)
Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue
Mi H. Lee et al.
KIDNEY INTERNATIONAL (2008)
Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system
Atsuhito Saiki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Gijs H. Goossens
PHYSIOLOGY & BEHAVIOR (2008)
Medicine - Can we nip obesity in its vascular bud?
C. Ronald Kahn
SCIENCE (2008)
Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration
M. E. Rausch et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes
Bohan Wang et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Tonje Amb Aksnes et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice
Jianping Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome
Mahmut I. Yilmaz et al.
NEPHROLOGY (2007)
Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'
M. Lundgren et al.
DIABETOLOGIA (2007)
Endocrine role of the renin-angiotensin system in human adipose tissue and muscle -: Effect of β-adrenergic stimulation
Gijs H. Goossens et al.
HYPERTENSION (2007)
Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes
P. S. Leung
DIABETIC MEDICINE (2007)
Angiotensin II: a hormone that affects lipid metabolism in adipose tissue
G. H. Goossens et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Effects of angiotensin II type 1 receptor blockade on β-cell function in humans
Syed Bokhari et al.
DIABETES CARE (2007)
Improvement of insulin sensitivity by antagonism of the renin-angiotensin system
Erik J. Henriksen
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation
Naomi Hosogai et al.
DIABETES (2007)
Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects
G. H. Goossens et al.
DIABETOLOGIA (2006)
Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation
A. Kurata et al.
KIDNEY INTERNATIONAL (2006)
Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate
Zhen Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease
Carlos M. Ferrario et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Beneficial effects of candesartan, an angiotensin II type I receptor blocker, on β-cell function and morphology in db/db mice
Jiaqing Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Hemodynamic and metabolic responses to interstitial angiotensin II in normal weight and obese men
Michael Boschmann et al.
JOURNAL OF HYPERTENSION (2006)
The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects
M. Boschmann et al.
HORMONE AND METABOLIC RESEARCH (2006)
Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle
LH Clerk et al.
DIABETES (2006)
Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes
BY Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans
GH Goossens et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets
R Lupi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes
KY Chu et al.
DIABETES (2006)
Role of the renin-angiotensin system in the endocrine pancreas: Implications for the development of diabetes
C Tikellis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie et al.
DIABETES CARE (2005)
Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat
JA Sloniger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf et al.
DIABETOLOGIA (2005)
Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat
C Tikellis et al.
DIABETES (2004)
Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats
SH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets
T Lau et al.
DIABETOLOGIA (2004)
Obesity decreases perioperative tissue oxygenation
B Kabon et al.
ANESTHESIOLOGY (2004)
Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity
M Furuhashi et al.
JOURNAL OF HYPERTENSION (2004)
Adipokines: inflammation and the pleiotropic role of white adipose tissue
P Trayhurn et al.
BRITISH JOURNAL OF NUTRITION (2004)
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
D Fliser et al.
CIRCULATION (2004)
Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo
MA Vincent et al.
DIABETES (2004)
Angiotensin II-Induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects
GH Goossens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Impaired microvascular function in obesity -: Implications for obesity-associated microangiopathy, hypertension, and insulin resistance
RT de Jongh et al.
CIRCULATION (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension
M Furuhashi et al.
HYPERTENSION (2003)
Blood flow and muscle metabolism: a focus on insulin action
MG Clark et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity
P Schling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats
MG Wallis et al.
DIABETES (2002)
Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling
T Ogihara et al.
HYPERTENSION (2002)
Metabolic and hemodynamic responses to exercise in subcutaneous adipose tissue and skeletal muscle
M Boschmann et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2002)
Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity
F Karpe et al.
DIABETES (2002)
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors
J Janke et al.
DIABETES (2002)
Metabolic and hemodynamic response of adipose tissue to angiotensin II
M Boschmann et al.
OBESITY RESEARCH (2001)
Adipose tissue and the insulin resistance syndrome
KN Frayn
PROCEEDINGS OF THE NUTRITION SOCIETY (2001)
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance
C Weyer et al.
DIABETOLOGIA (2000)
Physiology and pathophysiology of the adipose tissue renin-angiotensin system
S Engeli et al.
HYPERTENSION (2000)
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: A double-blind, placebo-controlled crossover trial
JR Petrie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril
JP New et al.
DIABETIC MEDICINE (2000)
分享论文
